Home > Healthcare > Medical Devices > Diagnostic Devices > Male Infertility Market

Male Infertility Market Share

Report ID: GMI10497
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Male Infertility Market Share

The male infertility sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative infertility therapies leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes. Smaller players focus towards offering male infertility therapies at lower prices, to compete with established players.

Male Infertility Market Companies

Some of the eminent market participants operating in the male infertility industry include:

Andrology Solutions
ASKA Pharmaceutical Co., Ltd.
AdvaCare Pharma
Bayer AG
CinnaGen Co.
CaerusBiotech
Endo International plc
HalotechDNA
Intas Pharmaceuticals Ltd.
Merck KGaA
Sanofi
SCSA Diagnostics, Inc
The Cooper Companies, Inc.
Vitrolife Group
Zydus Lifesciences Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Male infertility market size was valued at USD 4 billion in 2023 and is estimated to grow at 4.7% CAGR from 2024 to 2032, driven by the rapid growth in assisted reproductive technologies.

The hospitals pharmacies segment accounted for USD 2.1 billion in 2023 and will grow rapidly through 2032, as hospital pharmacies have access to a wide range of fertility medications.

U.S male infertility market size is projected to reach USD 2.2 billion by 2032, driven by technological innovations in reproductive medicine and male infertility treatment.

Endo International plc, HalotechDNA, Intas Pharmaceuticals Ltd, Merck KGaA, Sanofi, SCSA Diagnostics, Inc, and The Cooper Companies, Inc. among others.